Proscia Inc., a Philadelphia-based provider of digital and computational pathology solutions, said that NASA’s Jet Propulsion Laboratory and the National Cancer Institute Consortium for Molecular Characterization of Screen-Detected Lesions, coordinated by Baylor College of Medicine, have deployed Proscia’s Concentriq platform to advance biomedical research on improving cancer treatment.